Effects of methimazole on the elimination of irinotecan

PURPOSE: To study the possible pharmacokinetic and pharmacodynamic interactions between irinotecan and methimazole. METHODS: A patient treated for colorectal cancer with single agent irinotecan received methimazole co-medication for Graves’ disease. Irinotecan pharmacokinetics and side effects were...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: van der Bol, Jessica M., Visser, Theo J., Loos, Walter J., de Jong, Floris A., Wiemer, Erik A. C., van Aken, Maarten O., Planting, Andre S., Schellens, Jan H., Verweij, Jaap, Mathijssen, Ron H. J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer-Verlag 2010
Pynciau:
Short Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3016232/
https://ncbi.nlm.nih.gov/pubmed/20680278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-010-1414-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg